Patient interest in and clinician reservations on polygenic embryo screening: a qualitative study of stakeholder perspectives
Authors:
- 12 March 2024
- journal article
- research article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 41 (5) , 1221-1231
Abstract
Purpose We explored and compared perspectives of reproductive endocrinology and infertility specialists (REIs) and in vitro fertilization (IVF) patients regarding polygenic embryo screening (PES), a new type of preimplantation screening that estimates the genetic chances of developing polygenic conditions and traits in the future. Methods Qualitative thematic analysis of semi-structured interviews with US-based REIs and IVF patients. Results Clinicians and patients often held favorable views of screening embryos for physical or psychiatric conditions, though clinicians tended to temper their positive attitudes with specific caveats. Clinicians also expressed negative views about screening embryos for traits more frequently than patients, who generally held more positive views. Most clinicians were either unwilling to discuss or offer PES to patients or were willing to do so only under certain circumstances, while many patients expressed interest in PES. Both stakeholder groups envisioned multiple potential benefits or uses of PES and raised multiple potential, interrelated concerns about PES. Conclusion A gap exists between clinician and patient attitudes toward PES; clinicians generally maintained reservations about such screening and patients indicated interest in it. Clinicians and patients sometimes imagined using PES to prepare for the birth of a predisposed or “affected” individual—a rationale that is often associated with prenatal testing. Many clinicians and patients held different attitudes depending on what is specifically screened, despite the sometimes blurry distinction between conditions and traits. Considerations raised by clinicians and patients may help guide professional societies in developing guidelines to navigate the uncertain terrain of PES.Keywords
All Related Versions
Funding Information
- National Human Genome Research Institute (R01HG011711)
This publication has 34 references indexed in Scilit:
- Clinical genetic counseling and translation considerations for polygenic scores in personalized risk assessments: A Practice Resource from the National Society of Genetic CounselorsJournal of Genetic Counseling, 2023
- PREIMPLANTATION TESTING OF EMBRYOS FOR POLYGENIC RELATED CONDITIONS: THE ETHICAL CONCERNS SURROUNDING IT AND THE POSITION OF GENETIC COUNSELORSFertility and Sterility, 2021
- Ethical and moral perspectives of individuals who considered/used preimplantation (embryo) genetic testingJournal of Genetic Counseling, 2021
- Is preparation a good reason for prenatal genetic testing? Ethical and critical questionsBirth Defects Research, 2020
- Screening Human Embryos for Polygenic Traits Has Limited UtilityCell, 2019
- Who Should Regulate Preimplantation Genetic Diagnosis in the United States?AMA Journal of Ethics, 2018
- RETIRED: Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinionFertility and Sterility, 2018
- Saturation in qualitative research: exploring its conceptualization and operationalizationQuality & Quantity, 2017
- RETIRED: Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee OpinionFertility and Sterility, 2017
- Serious genetic disorders: Can or should they be defined?*American Journal of Medical Genetics, 2002